BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gąsecka A, Borovac JA, Guerreiro RA, Giustozzi M, Parker W, Caldeira D, Chiva-Blanch G. Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment. Cardiovasc Drugs Ther 2021;35:215-29. [PMID: 33074525 DOI: 10.1007/s10557-020-07084-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 46] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Cabrera-Garcia D, Miltiades A, Yim P, Parsons S, Elisman K, Mansouri MT, Wagener G, Harrison NL. Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients. Int J Hematol 2022. [PMID: 35994163 DOI: 10.1007/s12185-022-03437-2] [Reference Citation Analysis]
2 Ratajczak J, Szczerbiński S, Kubica A. Occurrence and Temporal Variability of Out-of-Hospital Cardiac Arrest during COVID-19 Pandemic in Comparison to the Pre-Pandemic Period in Poland-Observational Analysis of OSCAR-POL Registry. J Clin Med 2022;11:4143. [PMID: 35887907 DOI: 10.3390/jcm11144143] [Reference Citation Analysis]
3 Liu C, Yan W, Shi J, Wang S, Peng A, Chen Y, Huang K. Biological Actions, Implications, and Cautions of Statins Therapy in COVID-19. Front Nutr 2022;9:927092. [DOI: 10.3389/fnut.2022.927092] [Reference Citation Analysis]
4 Walitt B, Johnson TP. The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. Curr Opin Neurol 2022;35:384-91. [PMID: 35674083 DOI: 10.1097/WCO.0000000000001051] [Reference Citation Analysis]
5 Cherneva R, Cherneva Z. Long COVID-19 Syndrome: Multiorgan Damage and Recommendations for Follow-Up and Rehabilitation. Acta Medica Bulgarica 2022;49:57-62. [DOI: 10.2478/amb-2022-0010] [Reference Citation Analysis]
6 Konwerski M, Gąsecka A, Opolski G, Grabowski M, Mazurek T. Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review. Biology (Basel) 2022;11:355. [PMID: 35336728 DOI: 10.3390/biology11030355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Costanzo M, Caterino M, Fedele R, Cevenini A, Pontillo M, Barra L, Ruoppolo M. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19. Int J Mol Sci 2022;23:2414. [PMID: 35269564 DOI: 10.3390/ijms23052414] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
8 P. S, Madhavan S, Pandurangan V. Incidence, Risk Factors, and Timing of Macrovascular Thrombosis in the Post-COVID-19 Elderly and Assessing the Need and Duration of Extended Thromboprophylaxis: A Prospective Study. Arch Clin Infect Dis 2021;16. [DOI: 10.5812/archcid.119593] [Reference Citation Analysis]
9 Case BC, Abramowitz J, Shea C, Rappaport H, Medranda GA, Yerasi C, Forrestal BJ, Chezar-Azerrad C, Zhang C, Satler LF, Ben-Dor I, Hashim H, Rogers T, Weintraub WS, Waksman R. Comparison of Outcomes in Patients With COVID-19 and Thrombosis Versus Those Without Thrombosis. Am J Cardiol 2021;160:106-11. [PMID: 34607645 DOI: 10.1016/j.amjcard.2021.08.038] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chojecka D, Pytlos J, Zawadka M, Andruszkiewicz P, Szarpak Ł, Dzieciątkowski T, Jaguszewski MJ, Filipiak KJ, Gąsecka A. How to Maintain Safety and Maximize the Efficacy of Cardiopulmonary Resuscitation in COVID-19 Patients: Insights from the Recent Guidelines. J Clin Med 2021;10:5667. [PMID: 34884368 DOI: 10.3390/jcm10235667] [Reference Citation Analysis]
11 Tafazoli A, Anil Kumar S, Othman M. Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications. Platelets 2021;:1-6. [PMID: 34847829 DOI: 10.1080/09537104.2021.1961718] [Reference Citation Analysis]
12 Drakos P, Volteas P, Naeem Z, Asencio AA, Cleri NA, Alkadaa LN, Oganov A, Gammel T, Saadon JR, Bannazadeh M, Tassiopoulos AK, Mikell CB, Rubano J, Pryor A, Spaniolas K, Mofakham S. Aggressive Anticoagulation May Decrease Mortality in Obese Critically Ill COVID-19 Patients. Obes Surg 2021. [PMID: 34816357 DOI: 10.1007/s11695-021-05799-8] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Laubscher GJ, Lourens PJ, Venter C, Kell DB, Pretorius E. TEG®, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy. J Clin Med 2021;10:5381. [PMID: 34830660 DOI: 10.3390/jcm10225381] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
14 Baltaziak K, Szpringer A, Czarnek-Chudzik A, Onyszkiewicz M, Toro MD, Pankowska A, Pietura R, Rejdak R, Nowomiejska K. Quadrantanopia as the only symptom of post-COVID stroke in the occipital pole: Case report. Medicine (Baltimore) 2021;100:e27542. [PMID: 34871216 DOI: 10.1097/MD.0000000000027542] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Tomerak S, Khan S, Almasri M, Hussein R, Abdelati A, Aly A, Salameh MA, Saed Aldien A, Naveed H, Elshazly MB, Zakaria D. Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review. Scand J Immunol 2021;94. [DOI: 10.1111/sji.13097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Jha NK, Sharma C, Meeran MFN, Jha SK, Dwivedi VD, Gupta PK, Dey A, Kesari KK, Ojha S. Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19. Immuno 2021;1:285-304. [DOI: 10.3390/immuno1030020] [Reference Citation Analysis]
17 Kyriakoulis KG, Kollias A, Kyriakoulis IG, Kyprianou IA, Papachrysostomou C, Makaronis P, Kotronias RA, Terentes-Printzios D, Toskas I, Mikhailidis DP. Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports. Curr Vasc Pharmacol 2021. [PMID: 34431465 DOI: 10.2174/1570161119666210824160332] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
18 Yan Z, Yang M, Lai CL. Long COVID-19 Syndrome: A Comprehensive Review of Its Effect on Various Organ Systems and Recommendation on Rehabilitation Plans. Biomedicines 2021;9:966. [PMID: 34440170 DOI: 10.3390/biomedicines9080966] [Cited by in Crossref: 13] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
19 Tiotiu A, Chong Neto H, Bikov A, Kowal K, Steiropoulos P, Labor M, Cherrez-Ojeda I, Badellino H, Emelyanov A, Garcia R, Guidos G. Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases. Expert Rev Respir Med 2021;15:1035-48. [PMID: 34253132 DOI: 10.1080/17476348.2021.1951707] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
20 García-Callejo FJ. [Blood viscosity in Covid-19 patients with sudden deafness]. Acta Otorrinolaringol Esp (Engl Ed) 2021. [PMID: 34305143 DOI: 10.1016/j.otorri.2021.07.001] [Reference Citation Analysis]
21 Cicco S, Vacca A, Cariddi C, Carella R, Altamura G, Solimando AG, Lauletta G, Pappagallo F, Cirulli A, Stragapede A, Susca N, Grasso S, Ria R. Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19. Diagnostics (Basel) 2021;11:1271. [PMID: 34359355 DOI: 10.3390/diagnostics11071271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Viurcos-Sanabria R, Escobedo G. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. World J Diabetes 2021; 12(7): 1026-1041 [PMID: 34326952 DOI: 10.4239/wjd.v12.i7.1026] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Subramaniam S, Ruf W, Bosmann M. Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019. Br J Pharmacol 2021. [PMID: 34235728 DOI: 10.1111/bph.15587] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
24 Sandor-Keri J, Benedek I, Polexa S, Benedek I. The Link between SARS-CoV-2 Infection, Inflammation and Hypercoagulability-Impact of Hemorheologic Alterations on Cardiovascular Mortality. J Clin Med 2021;10:3015. [PMID: 34300181 DOI: 10.3390/jcm10143015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
25 Olszewska-Parasiewicz J, Szarpak Ł, Rogula S, Gąsecka A, Szymańska U, Kwiatkowska M, Jaguszewski MJ, Sierpiński R, Zaczyński A, Wierzba W, Kosior DA. Statins in COVID-19 Therapy. Life (Basel) 2021;11:565. [PMID: 34208435 DOI: 10.3390/life11060565] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Szwed P, Gąsecka A, Zawadka M, Eyileten C, Postuła M, Mazurek T, Szarpak Ł, Filipiak KJ. Infections as Novel Risk Factors of Atherosclerotic Cardiovascular Diseases: Pathophysiological Links and Therapeutic Implications. J Clin Med 2021;10:2539. [PMID: 34201137 DOI: 10.3390/jcm10122539] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
27 Alpers DH. Is the Intestine a Portal of Entry for the Serious COVID-19 Complications of Endotoxemia and Thrombosis? Clin Transl Gastroenterol 2021;12:e00367. [PMID: 34092778 DOI: 10.14309/ctg.0000000000000367] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Buso G, Becchetti C, Berzigotti A. Acute splanchnic vein thrombosis in patients with COVID-19: A systematic review. Dig Liver Dis 2021;53:937-49. [PMID: 34120860 DOI: 10.1016/j.dld.2021.05.021] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
29 Siwik D, Gajewska M, Karoń K, Pluta K, Wondołkowski M, Wilimski R, Szarpak Ł, Filipiak KJ, Gąsecka A. Pleiotropic Effects of Acetylsalicylic Acid after Coronary Artery Bypass Grafting-Beyond Platelet Inhibition. J Clin Med 2021;10:2317. [PMID: 34073241 DOI: 10.3390/jcm10112317] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Thachil J. Lessons learnt from COVID-19 coagulopathy. EJHaem 2021. [PMID: 34226900 DOI: 10.1002/jha2.228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
31 Kwee RM, Adams HJA, Kwee TC. Pulmonary embolism in patients with COVID-19 and value of D-dimer assessment: a meta-analysis. Eur Radiol 2021. [PMID: 33966132 DOI: 10.1007/s00330-021-08003-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
32 Rahman S, Montero MTV, Rowe K, Kirton R, Kunik F Jr. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol 2021;14:601-21. [PMID: 33705239 DOI: 10.1080/17512433.2021.1902303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
33 Ilias I, Goulas S, Zabuliene L. Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19. World J Clin Cases 2021; 9(12): 2711-2720 [PMID: 33969054 DOI: 10.12998/wjcc.v9.i12.2711] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Esmaeeli H, Ghaderian M, Zanjani KS, Ghalibafan SF, Mahdizadeh M, Aelami MH. COVID-19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran. Case Rep Pediatr 2021;2021:6690695. [PMID: 33959402 DOI: 10.1155/2021/6690695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 To KK, Sridhar S, Chiu KH, Hung DL, Li X, Hung IF, Tam AR, Chung TW, Chan JF, Zhang AJ, Cheng VC, Yuen KY. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microbes Infect 2021;10:507-35. [PMID: 33666147 DOI: 10.1080/22221751.2021.1898291] [Cited by in Crossref: 17] [Cited by in F6Publishing: 63] [Article Influence: 17.0] [Reference Citation Analysis]
36 Parker WAE, Storey RF. Platelets and the Endothelium: Active Participants in Severe COVID-19 Infection. JACC Basic Transl Sci 2021;6:219-21. [PMID: 33778209 DOI: 10.1016/j.jacbts.2021.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Arai R, Fukamachi D, Ebuchi Y, Migita S, Morikawa T, Monden M, Takei N, Tamaki T, Kojima K, Akutsu N, Murata N, Kitano D, Okumura Y. Impact of the COVID-19 outbreak on hospitalizations and outcomes in patients with acute myocardial infarction in a Japanese Single Center. Heart Vessels 2021;36:1474-83. [PMID: 33743048 DOI: 10.1007/s00380-021-01835-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Borkowska MJ, Jaguszewski MJ, Koda M, Gasecka A, Szarpak A, Gilis-Malinowska N, Safiejko K, Szarpak L, Filipiak KJ, Smereka J. Impact of Coronavirus Disease 2019 on Out-of-Hospital Cardiac Arrest Survival Rate: A Systematic Review with Meta-Analysis. J Clin Med 2021;10:1209. [PMID: 33803944 DOI: 10.3390/jcm10061209] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
39 Aliotta A, Bertaggia Calderara D, Zermatten MG, Marchetti M, Alberio L. Thrombocytopathies: Not Just Aggregation Defects-The Clinical Relevance of Procoagulant Platelets. J Clin Med 2021;10:894. [PMID: 33668091 DOI: 10.3390/jcm10050894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
40 Malinowska B, Baranowska-Kuczko M, Kicman A, Schlicker E. Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19. Int J Mol Sci 2021;22:1986. [PMID: 33671463 DOI: 10.3390/ijms22041986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
41 Dziedzic A, Saluk-Bijak J, Miller E, Niemcewicz M, Bijak M. The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis. Int J Mol Sci 2021;22:1804. [PMID: 33670394 DOI: 10.3390/ijms22041804] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
42 Franchini M, Glingani C, Morandi M, Corghi G, Cerzosimo S, Beduzzi G, Storti A, Di Stasi V, Rastrelli G, Vignozzi L, Mengoli C, Garuti M, Beccaria M, Inglese F, Caruso B, Petilino RA, Amato M, Nicchio M, Pagani M, Bellani A, Castelli G, Casari S, De Donno G. Safety and Efficacy of Convalescent Plasma in Elderly COVID-19 Patients: The RESCUE Trial. Mayo Clin Proc Innov Qual Outcomes 2021;5:403-12. [PMID: 33585799 DOI: 10.1016/j.mayocpiqo.2021.01.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
43 Ouarradi AE, Chekhlabi N, Elharras M, Bensahi I, Oualim S, Merzouk F, Abdeladim S, Sabry M, Dini N. Acute pulmonary embolism in a child following SARS-CoV-2 infection: a case report. Pan Afr Med J 2021;38:125. [PMID: 33912295 DOI: 10.11604/pamj.2021.38.125.27954] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
44 Balanchivadze N, Xie P, Kuriakose P, Barthel B, Dabak V. Transient Anti-Phospholipid Antibodies in Two Patients With COVID-19. Cureus 2021;13:e13026. [PMID: 33665050 DOI: 10.7759/cureus.13026] [Reference Citation Analysis]
45 Ménager P, Brière O, Gautier J, Riou J, Sacco G, Brangier A, Annweiler C, Geria-Covid Study Group OBOT. Regular Use of VKA Prior to COVID-19 Associated with Lower 7-Day Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Cohort Study. Nutrients 2020;13:E39. [PMID: 33374341 DOI: 10.3390/nu13010039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
46 Maiuolo J, Mollace R, Gliozzi M, Musolino V, Carresi C, Paone S, Scicchitano M, Macrì R, Nucera S, Bosco F, Scarano F, Zito MC, Ruga S, Tavernese A, Mollace V. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection. Int J Mol Sci 2020;21:E9309. [PMID: 33291346 DOI: 10.3390/ijms21239309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]